Flipside Finance
NV

Novo Nordisk A/S

NVOEquity
$38.43-0.39%
24h Volume: $0.01B

AI Summary

Updated 4h ago

Novo Nordisk A/S (NVO) is showing an interesting divergence

Novo Nordisk A/S (NVO) is showing an interesting divergence. Price has pulled back — extension indicators are in the lower portion of their historical range — but buying pressure is holding up. Flow indicators remain above average despite the price weakness. Price is currently near a structural support zone at $38 -- $39, 1% below current levels. For reference: Flow Score 25/100, Trend & Momentum Score 13/100.

42NEUTRAL

Asset Health Metrics

13
Trend & Momentum
25
Money Flow
10
Risk

Technical Analysis

Market Positioning

Where does this asset sit across four dimensions? Extension (how stretched price is vs its own history), Momentum (RSI, MACD, rate of change), Flow (volume and money flow), and Volatility (how quiet or active). Each bar shows a 0–100 percentile compared to the last year of data. Key levels show the nearest demand and supply zones from our confluence analysis.

Extension
[avg: 29th]
29thpercentile
Low
Normal
High
29th percentile
Momentum
[avg: 36th]
36thpercentile
Low
Normal
High
36th percentile
Flow
[avg: 60th]
60thpercentile
Low
Normal
High
60th percentile
Volatility
[avg: 74th]
74thpercentile
Low
Normal
High
74th percentile

Key Levels

Demand: $38–$39 (0.6% below)
score: 1.92
Supply: $40–$40 (3.8% above)
score: 1.30
View full Key Levels section →

Looking at the full picture for Novo Nordisk A/S (NVO): extension is below average (29th percentile), momentum is slightly below average (36th percentile), flow is slightly above average (60th percentile), volatility is above average (74th percentile). The picture is mixed. flow is above average while extension is below average. There is no dominant theme that makes this a clear setup in either direction. Watch whether extension drops further toward the support zone at $38 -- $39 (1% below). A combination of low extension and low momentum at a structural support level would be a more significant confluence.

Conclusion

Novo Nordisk A/S (NVO) is in a mixed position. Some indicators are above average, others below, but nothing is at an extreme level that defines the current setup strongly in either direction. There is not a strong signal here in either direction. This is an asset to watch rather than act on right now. These readings update daily. Flipside shows what is happening now, grounded in the data — not what will happen next.

Your portfolio. Your context. Smarter decisions.

Connect your holdings and let the Flipside Agent analyze market changes through the lens of your portfolio.

AI + Portfolio

Personalized insights based on your actual holdings

Daily Briefing

Major market movements delivered to your inbox

Watchlists

Track the assets that matter most to you

No credit card required